EUVIMEDEUVIMED entdecken
Klinische StudieSystematische ÜbersichtMetaanalyse

Impact of endoscopic ultrasound in cholangiocarcinoma staging: a systematic review and meta-analysis

Nasruddin Sabrie iD, Michael Youssef iD, Yibing Ruan, Marcus Vaska, Samir C Grover, Paul D James, Nauzer Forbes iD, Vinay Chandrasekhara iD, Lydi M J W van Driel, David M de Jong iD, Rishad Khan iD

Endoscopy · 12.10.2026

DOI: 10.1055/a-2944-4167 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Endoscopy, erschienen am 12.10.2026. Verfasst von Nasruddin Sabrie und 10 weiteren Autor:innen. Beteiligte Einrichtung: University of Toronto, Gastroenterology and Hepatology, Department of Medicine, Canada, Toronto. Die Arbeit nennt 25 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate staging is crucial for managing cholangiocarcinoma (CCA). Endoscopic ultrasound with tissue acquisition (EUS-TA) may enhance cross-sectional imaging-based staging; however, the impact of EUS on CCA management decision-making is unclear. 6 electronic databases were searched through to 10 July 2025 for studies on EUS-TA in staging CCA cases eligible for surgical resection or liver transplantation. The primary outcome was the pooled proportion of patients excluded from curative-intent surgery based on the EUS findings, which included newly detected findings and confirmation by EUS-TA of cross-sectional imaging findings. Secondary outcomes included the pooled incremental benefit of EUS (IBEUS) over cross-sectional imaging and EUS-specific adverse events. The IBEUS was defined as the proportion of patients with malignant lymph nodes identified by EUS-TA but not by cross-sectional imaging, relative to all patients who underwent cross-sectional imaging. 9 studies with 831 patients were included. The rate of exclusion from curative-intent surgery based on EUS findings was 10% overall (95%CI 6%–18%; 9 studies), 7% for perihilar CCA (pCCA; 95%CI 2%–19%; 5 studies), 10% for those planned for resection (95%CI 4%–22%; 5 studies), and 8% for those planned for transplantation (95%CI 3%–22%; 3 studies). The pooled IBEUS was 3% (95%CI 1%–10%; 5 studies) overall, 4% (95%CI 1%–17%; 3 studies) for pCCA, 1% (95%CI 0%–3%; 2 studies) in patients intended for operative resection, and 7% (95%CI 1%–26%; 2 studies) in those intended for transplantation. EUS may impact CCA staging and support treatment decisions.

Autor:innen und Institutionen

  • University of Toronto, Gastroenterology and Hepatology, Department of Medicine, Canada, Toronto.
  • University of Calgary, Oncology, Canada, Calgary.
  • Cancer Control Alberta, Cancer Epidemiology and Prevention Research, Canada, Calgary.
  • Alberta Health Services, Knowledge Resource Service, Canada, Calgary.
  • Scarborough Health Network, Research Institute, Canada, Toronto.
  • The University Health Network, Medicine, Canada, Toronto.

ORCID-Profile: Nasruddin Sabrie, Michael Youssef, Nauzer Forbes, Vinay Chandrasekhara, David M de Jong, Rishad Khan

Zitieren

APA

Sabrie, N., Youssef, M., Ruan, Y., Vaska, M., Grover, S. C., James, P. D., Forbes, N., Chandrasekhara, V., van Driel, L. M. J. W., de Jong, D. M., & Khan, R. (2026). Impact of endoscopic ultrasound in cholangiocarcinoma staging: a systematic review and meta-analysis. Endoscopy. https://doi.org/10.1055/a-2944-4167

Vancouver

Sabrie N, Youssef M, Ruan Y, Vaska M, Grover SC, James PD, et al. Impact of endoscopic ultrasound in cholangiocarcinoma staging: a systematic review and meta-analysis. Endoscopy. 2026. doi:10.1055/a-2944-4167

BibTeX
@article{Sabrie2026,
  author = {Sabrie, Nasruddin and Youssef, Michael and Ruan, Yibing and Vaska, Marcus and Grover, Samir C and James, Paul D and Forbes, Nauzer and Chandrasekhara, Vinay and van Driel, Lydi M J W and de Jong, David M and Khan, Rishad},
  title = {Impact of endoscopic ultrasound in cholangiocarcinoma staging: a systematic review and meta-analysis},
  journal = {Endoscopy},
  year = {2026},
  doi = {10.1055/a-2944-4167}
}
Kostenlos starten →